Troponin Elevation in Patients Undergoing Percutaneous Hepatic Perfusion for Metastatic Uveal Melanoma
Cancer Control · 2024
DOI: 10.1177/10732748241246898 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Control, 2024. Verfasst von Sanjay Chandrasekhar und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Sciences, Morsani College of Medicine, University of South Florida, Tampa, FL, USA. Hauptthemen laut MEDLINE: Melphalan, Liver Neoplasms, Melanoma, Uveal Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Delcath Systems, Inc.
Abstract (Originalsprache)
Background
Percutaneous Hepatic Perfusion (PHP) is a liver directed regional therapy recently FDA approved for metastatic uveal melanoma to the liver involving percutaneous isolation of liver, saturation of the entire liver with high-dose chemotherapy and filtration extracorporeally though in line filters and veno-venous bypass. The procedure is associated with hemodynamic shifts requiring hemodynamic support and blood product resuscitation due to coagulopathy.
Objective
To assess the cardiac safety and subsequent clinically significant sequalae of this therapy.
Methods
Consecutive PHP procedures done at our center between 2010-2022 were assessed retrospectively. Cardiac risk factors, post procedural cardiac enzymes, electrocardiograms, and transthoracic echocardiograms along with 90-day cardiac outcomes were reviewed. All data were reviewed by cardio-oncologists at our institution.
Results
Of 37 patients reviewed, mean age was 63 years and 57% were women. 132 procedures were performed with an average of 3.57 procedures per patient. 68.6% of patients had elevated troponin during at least 1 procedure. No patients were found to have acute coronary syndrome, heart failure, unstable arrhythmias, or cardiac death. No patients had notable echocardiographic changes. 10.8% of patients with positive troponin had asymptomatic transient electrocardiographic changes not meeting criteria for myocardial infarction. One patient had non-sustained ventricular tachycardiac intra-operatively which did not recur subsequently. Three patients died from non-cardiac causes within 90-days. There was no oncology treatment interruption, even in those with troponin elevation. In multivariable analysis, a history of hyperlipidemia was a predictor of postoperative troponin elevation. ( P = .042).
Conclusion
Percutaneous Hepatic Perfusion is safe and associated with a transient, asymptomatic troponin elevation peri-operatively without major adverse cardiac events at 90 days. The observed troponin elevation is likely secondary to coronary demand-supply mismatch related to procedural hemodynamic shifts, hypotension, and anemia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiovascular Sciences, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.
- Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
- Department of Cardio-Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
- Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
- Department of Oncologic Sciences, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.
ORCID-Profile: Mohammed Alomar
Förderung
- Delcath Systems, Inc
Zitieren
APA
Chandrasekhar, S., Perez, M., Niaz, Z., Ekram, J., Lal, N., Koly, S., Cao, B., Zager, J. S., & Alomar, M. (2024). Troponin Elevation in Patients Undergoing Percutaneous Hepatic Perfusion for Metastatic Uveal Melanoma. Cancer Control. https://doi.org/10.1177/10732748241246898
Vancouver
Chandrasekhar S, Perez M, Niaz Z, Ekram J, Lal N, Koly S, et al. Troponin Elevation in Patients Undergoing Percutaneous Hepatic Perfusion for Metastatic Uveal Melanoma. Cancer Control. 2024. doi:10.1177/10732748241246898
BibTeX
@article{Chandrasekhar2024,
author = {Chandrasekhar, Sanjay and Perez, Matthew and Niaz, Zurain and Ekram, Jahanzaib and Lal, Neelam and Koly, Sarah and Cao, Biwei and Zager, Jonathan S and Alomar, Mohammed},
title = {Troponin Elevation in Patients Undergoing Percutaneous Hepatic Perfusion for Metastatic Uveal Melanoma},
journal = {Cancer Control},
year = {2024},
doi = {10.1177/10732748241246898}
}
EUVIMED